JPS5371062A - 55*hydroxy*substituted*methyl** 2*33dihydrobenzofurann22 carboxylate and derivatives thereof - Google Patents
55*hydroxy*substituted*methyl** 2*33dihydrobenzofurann22 carboxylate and derivatives thereofInfo
- Publication number
- JPS5371062A JPS5371062A JP14578177A JP14578177A JPS5371062A JP S5371062 A JPS5371062 A JP S5371062A JP 14578177 A JP14578177 A JP 14578177A JP 14578177 A JP14578177 A JP 14578177A JP S5371062 A JPS5371062 A JP S5371062A
- Authority
- JP
- Japan
- Prior art keywords
- carboxylate
- hydroxy
- derivatives
- substituted
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/747,840 US4100294A (en) | 1976-12-06 | 1976-12-06 | 5-(Hydroxy (substituted) methyl)-2,3-dihydrobenzo furan-2-carboxylic acid and its derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5371062A true JPS5371062A (en) | 1978-06-24 |
Family
ID=25006865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP14578177A Pending JPS5371062A (en) | 1976-12-06 | 1977-12-06 | 55*hydroxy*substituted*methyl** 2*33dihydrobenzofurann22 carboxylate and derivatives thereof |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4100294A (enExample) |
| JP (1) | JPS5371062A (enExample) |
| DE (1) | DE2754068A1 (enExample) |
| DK (1) | DK520077A (enExample) |
| FR (1) | FR2372818A1 (enExample) |
| GB (1) | GB1555837A (enExample) |
| NL (1) | NL7712800A (enExample) |
| SE (1) | SE7713244L (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4189496A (en) * | 1978-02-16 | 1980-02-19 | Merck & Co., Inc. | 2,3-Dihydro-5-thienylmethyl and furylmethyl-6-substituted and 6,7-disubstituted-benzofuran-2-carboxylic acid |
| EP0019955A1 (en) * | 1979-05-16 | 1980-12-10 | Shell Internationale Researchmaatschappij B.V. | Benzofurancarboxylic acid derivatives, their preparation and their inclusion in lipogenesis inhibiting compositions |
| US4456612A (en) * | 1981-09-08 | 1984-06-26 | Abbott Laboratories | Benzisoxazole carboxylic acids |
| US4435422A (en) * | 1982-09-15 | 1984-03-06 | Abbott Laboratories | 5-Substituted 2,3-dihydrobenzofuran-2-carboxylic acids and their use in diuretic compositions |
| US4490384A (en) * | 1983-02-23 | 1984-12-25 | Abbott Laboratories | Benzisoxazole carboxylic acids |
| US4560558A (en) * | 1983-05-16 | 1985-12-24 | Abbott Laboratories | 3-Alkyl-8-chloro-5,6-dihydrofuro-[3,2-f]-1,2-benzisoxazole-6-carboxylic acids |
| US4663347A (en) * | 1983-10-31 | 1987-05-05 | Merck Frosst Canada, Inc. | Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis |
| US4822803A (en) * | 1983-10-31 | 1989-04-18 | Merck Frosst Canada, Inc. | Benzofuran 2-carboxylic acid hydrazides useful as inhibitors of leukotriene biosynthesis |
| US4933351A (en) * | 1983-10-31 | 1990-06-12 | Merck Frosst Canada, Inc. | Benzofuran 2-carbox amides useful as inhibitors of leukoriene biosynthesis |
| US4713393A (en) * | 1985-04-25 | 1987-12-15 | Merck & Co., Inc. | Phenylpropyl-2,3-dihydrobenzofurans useful as anti-inflammatory agents |
| US4654365A (en) * | 1985-09-26 | 1987-03-31 | Merck & Co., Inc. | 2,3-dihydro-5-(3-oxo-2-cyclohexen-1-yl)-2-benzofurancarboxylic acids, and their salts useful in the treatment of brain injury |
| US6150402A (en) * | 1994-08-15 | 2000-11-21 | Loma Linda University Medical Center | Natriuretic compounds |
| US6858614B2 (en) * | 2002-02-19 | 2005-02-22 | Parion Sciences, Inc. | Phenolic guanidine sodium channel blockers |
| US6858615B2 (en) * | 2002-02-19 | 2005-02-22 | Parion Sciences, Inc. | Phenyl guanidine sodium channel blockers |
| US6903105B2 (en) | 2003-02-19 | 2005-06-07 | Parion Sciences, Inc. | Sodium channel blockers |
| US7745442B2 (en) | 2003-08-20 | 2010-06-29 | Parion Sciences, Inc. | Methods of reducing risk of infection from pathogens |
| AR086745A1 (es) | 2011-06-27 | 2014-01-22 | Parion Sciences Inc | 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida |
| SG11201504799QA (en) | 2012-12-17 | 2015-07-30 | Parion Sciences Inc | Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration |
| EP2931712B8 (en) | 2012-12-17 | 2018-05-23 | Parion Sciences, Inc. | 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds |
| US9102633B2 (en) | 2013-12-13 | 2015-08-11 | Parion Sciences, Inc. | Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4087542A (en) * | 1975-07-09 | 1978-05-02 | Merck & Co., Inc. | 2,3-Dihydro-6,7-disubstituted-5-acyl benzofuran-2-carboxylic acids |
-
1976
- 1976-12-06 US US05/747,840 patent/US4100294A/en not_active Expired - Lifetime
-
1977
- 1977-11-21 NL NL7712800A patent/NL7712800A/xx not_active Application Discontinuation
- 1977-11-23 DK DK520077A patent/DK520077A/da unknown
- 1977-11-23 SE SE7713244A patent/SE7713244L/xx unknown
- 1977-12-02 GB GB50360/77A patent/GB1555837A/en not_active Expired
- 1977-12-02 FR FR7736303A patent/FR2372818A1/fr active Granted
- 1977-12-05 DE DE19772754068 patent/DE2754068A1/de not_active Withdrawn
- 1977-12-06 JP JP14578177A patent/JPS5371062A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NL7712800A (nl) | 1978-06-08 |
| DK520077A (da) | 1978-06-07 |
| GB1555837A (en) | 1979-11-14 |
| DE2754068A1 (de) | 1978-06-08 |
| FR2372818B1 (enExample) | 1981-11-27 |
| FR2372818A1 (fr) | 1978-06-30 |
| SE7713244L (sv) | 1978-06-07 |
| US4100294A (en) | 1978-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS52105162A (en) | Phthleic derivatives and preparation thereof | |
| JPS5371062A (en) | 55*hydroxy*substituted*methyl** 2*33dihydrobenzofurann22 carboxylate and derivatives thereof | |
| IL59567A0 (en) | Oxiranylmethyltetrahydropyran derivative and its preparation | |
| JPS5334771A (en) | Thiazolidine derivative and its preparation | |
| JPS5334800A (en) | 55alkoxyimidazo *1*22a* quinolinee22carboxylic acid and derivative thereof | |
| JPS549281A (en) | 44aminomethyll11*3*3*33 triarylpropyl**44 arylpyperidine and derivative thereof | |
| JPS53132596A (en) | 22*2*22diaryllalkyl**11azabicyclo *2*2*2*octane and derivative thereof | |
| HK60184A (en) | 4-hydroxyphenylalkanolamine derivatives and preparation thereof | |
| JPS5344539A (en) | 22*33phenyll22 aminopropionyloxy* derivatives | |
| JPS5392784A (en) | 1*44dihydropyridine derivative and vasolidator drugs containing same | |
| JPS52148061A (en) | 66carboxymethyl thiocortisol and derivatives thereof | |
| JPS52139040A (en) | 22 and 33substituted enekephlin | |
| JPS53127491A (en) | 33*22aminoethylthio**66ethyll77oxoo 11azabicyclo*3*2*0*heptaa22enee22 carboxylate | |
| JPS53132582A (en) | 33*11piperadinyl**1*2*44benzotriazine and nnoxide | |
| ZA781598B (en) | 4-alkylthio-2-trifluoromethylalkanesulfonanilides and derivatives thereof | |
| GB2023599B (en) | Thienopyridone and furopyridone derivatives | |
| JPS5356607A (en) | 4*66dii00*aminoglycosyl** 1*33diaminocicrytol derivatives | |
| JPS5488272A (en) | 3*44methanoopyrrolidine derivatives and their manufacture | |
| JPS5365853A (en) | 15 * 166dihydroxyprostaglandin and like | |
| GB1542775A (en) | Seldomycin factor 5 derivatives | |
| JPS5283640A (en) | Benzyllphenoxyalkane carboxylate and derivatives thereof | |
| JPS54106465A (en) | 16*177pyrazolinoo and 16*177isopyrazolinoo 1*44pregnadiene derivative | |
| JPS54103863A (en) | 5*66dihydrooprostacycline derivative and its manufacture | |
| JPS52116462A (en) | 22oxoopyrrolidine derivative and preparation thereof | |
| GB1540347A (en) | 4-pyridyl-formimidoylglycyl-d-phenyl-glycine and derivatives |